The Gamaleya Center successfully developed and registered in 2015 two vector-based vaccines against Ebola fever (another vaccine was registered in 2020). The vaccines have been officially approved for use by the Russian Health Ministry. Аbout 2,000 people in Guinea received injections of Gamaleya vaccines in 2017-18. Gamaleya Research Center received an international patent for Ebola vaccine.
References and links for registration certificates, international patents and scientific publications about vaccines developed by the Gamaleya center
1. Gamaleya EBOLA vaccine
Clinical trial:
International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi
International patents:
Russian Health Ministry registration certificates:
GamEvac-Combi is a multivalent vector-based Ebola vaccine
GamEvac-Lyo is a multivalent vector-based Ebola vaccine
GamEvac is a vector-based Ebola vaccine
Scientific publications:
Useful links:
Russia and Rusal complete Ebola vaccinations in Guinea. Pharmaceutical Technology.